Abstract
Microbial biofilms are compact surface-attached communities that are usually formed of mixed species wherein microbes thrive together and compete for limited resources. Bacteria growing in biofilms are highly tolerant to antibiotics and recalcitrant to host immune system thus act as an important virulence factor playing a crucial role in infection persistence and pathogenesis. Bacterial biofilms have long been perceived as cause of chronic infections and diseases in humans. However, host–biofilm interactions are not well understood and thus, limiting our knowledge on how biofilms participate in disease pathogenesis. In this chapter, we will discuss underlying molecular mechanisms of biofilm formation and different interactions taking place during establishment of biofilms. Moreover, we will highlight in detail the role of biofilms as a virulence component and its contribution to the disease pathogenesis, focusing on important human infectious diseases and relevant animal models studying the fundamentals of pathogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- EPS:
-
Exopolysaccharides
- ECM:
-
Extracellular matrix
- MSCRAMMs:
-
Microbial surface components recognizing adhesive matrix molecule
- PIA:
-
Polysaccharide intercellular adhesin
- AHL:
-
Acyl-homoserine lactone
- AI-2:
-
Autoinducer-2
- HSL:
-
Homoserine lactone
References
Flemming H-C et al (2016) Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14:563
Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322
Geesey GG, Richardson WT, Yeomans HG et al (1977) Microscopic examination of natural sessile bacterial populations from an alpine stream. Can J Microbiol 23:1733–1736
Mortensen KP, Conley SN (1994) Film fill fouling in counterflow cooling towers: mechanisms and design. CTI J 15:10–25
Väisänen OM, Weber A, Bennasar A et al (1998) Microbial communities of printing paper machines. J Appl Microbiol 84(6):1069–1084
Angenent LT, Kelley ST, St Amand A et al (2005) Molecular identification of potential pathogens in water and air of a hospital therapy pool. Proc Natl Acad Sci U S A 102(13):4860–4865
Lebeaux D, Chauhan A, Rendueles O, Beloin C (2013) From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens 2:288–356
Stoodley P, Sauer K, Davies DG, Costerton JW (2002a) Biofilms as complex differentiated communities. Annu Rev Microbiol 56:187–209
Stoodley P, Cargo R, Rupp CJ et al (2002b) Biofilm material properties as related to shear-induced deformation and detachment phenomena. J Ind Microbiol Biotechnol 29:361–367
vanLoosdrecht MC, Heijnen JJ, Eberl H et al (2002a) Mathematical modelling of biofilm structures. Antonie Van Leeuwenhoek 81(1-4):245–256
Donlan RM (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8:881–890
Götz F (2002) Staphylococcus and biofilms. Mol Microbiol 43(6):1367–1378
Lasa I, Penadés JR (2006) Bap: a family of surface proteins involved in biofilm formation. Res Microbiol 157(2):99–107
Pratt LA, Kolter R (1998) Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 30(2):285–293
Geesey GG (2001) Bacterial behavior at surfaces. Curr Opin Microbiol 4(3):296–300
O’Toole GA, Kolter R (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30:295–304
Ventre I, Goodman AL, Vallet-Gely I et al (2006) Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. PNAS 103(1):171–176
Kearns DB, Chu F, Branda SS et al (2005) A master regulator for biofilm formation by Bacillus subtilis. Mol Microbiol 55:739–749
Branda SS, Chu F, Kearns DB et al (2006) A major protein component of the Bacillus subtilis biofilm matrix. Mol Microbiol 59:1229–1238
Zobell CE (1943) The effect of solid surfaces upon bacterial activity. J Bacteriol 46:39–56
Van Loosdrecht MC, Lyklema J, Norde W, Zehnder AJ (1990) Influence of interfaces on microbial activity. Microbiol Rev 54:75–87
Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193
Olsen A, Jonsson A, Normark S (1989) Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli. Nature 338(6217):652–655
Ben Nasr A, Olsén U, Sjöbring W, Müller-Esterl L (1996) Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Mol Microbiol 20(5):927–935
Reisner A, Haagensen JAJ, Schembri MA et al (2003) Development and maturation of Escherichia coli K-12 biofilms. Mol Microbiol 48(4):933–946
Fey PD, Olson ME (2010) Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol 5:917–933
Romeo T (2008) Bacterial biofilms. Preface. Curr Top Microbiol Immunol 322:v
Ulett GC, Valle J, Beloin C et al (2007) Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75(7):3233–3244
Anderson GG, Palermo JJ, Schilling JD et al (2003) Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105–107
Cucarella C, Solano C, Valle J et al (2001) Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 183:2888–2896
Ghannoum M, O’Toole GA (2001) Microbial biofilms. ASM Press, Washington DC
Fletcher M, Loeb GI (1979) The influence of substratum characteristics on the attachment of a marine Pseudomonas to solid surfaces. Appl Environ Microbiol 37:67–72
James GA, Beaudette L, Costerton JW (1995) Interspecies bacterial interactions in biofilms. J Ind Microbiol 15:257–262
Hofstad T (1992) Virulence factors in anaerobic bacteria. Eur J Clin Microbiol Infect Dis 11:1044–1048
Rabin N et al (2015) Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med Chem 7(4):493–512. https://doi.org/10.4155/fmc.15.6
Pacheco AR, Sperandio V (2009) Inter-kingdom signaling: chemical language between bacteria and host. Curr Opin Microbiol 12(2):192–198
Long T, Tu KC, Wang Y et al (2009) Quantifying the integration of quorum-sensing signals with single-cell resolution. PLoS Biol 7(3):e1000068
O’Toole G, Kaplan HB, Kolter R (2000) Biofilm formation as microbial development. Annu Rev Microbiol 54:49–79
Sakuragi Y, Kolter R (2007) Quorum-sensing regulation of the biofilm matrix genes (pel) of Pseudomonas aeruginosa. J Bacteriol 189(14):5383–5386
McGowan S et al (1995) Carbapenem antibiotic production in Erwinia carotovorais regulated by CarR, a homologue of the LuxR transcriptional activator. Microbiology 141:541–550
Davey ME, O’Toole GA (2000) Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 64:847–867
Boles BR, Thoendel M, Singh PK (2004) Self-generated diversity produces “insurance effects” in biofilm communities. Proc Natl Acad Sci U S A 101:16630–16635
Kerr B, Riley MA, Feldman MW, Bohannan BJ (2002) Local dispersal promotes biodiversity in a real-life game of rock-paper scissors. Nature 418:171–174
Li YH, Hanna MN, Svensater G et al (2001) Cell density modulates acid adaptation in Streptococcus mutans: implications for survival in biofilms. J Bacteriol 183:6875–6884
Butler MT, Wang Q, Harshey RM (2010) Cell density and mobility protect swarming bacteria against antibiotics. Proc Natl Acad Sci U S A 107:3776–3781
Burmølle M, Ren D, Bjarnsholt T, Sørensen SJ (2014) Interactions in multispecies biofilms: do they actually matter? Trends Microbiol 22:84–91
Elias S, Banin E (2012) Multi-species biofilms: living with friendly neighbors. FEMS Microbiol Rev 36:990–1004
Foster KR, Bell T (2012) Competition, not cooperation, dominates interactions among culturable microbial species. Curr Biol 22:1845–1850
Whittaker CJ, Klier CM, Kolenbrander PE (1996) Mechanisms of adhesion by oral bacteria. Annu Rev Microbiol 50:513–552
Poltak SR, Cooper VS (2011) Ecological succession in long-term experimentally evolved biofilms produces synergistic communities. ISME J 5:369–378
Ramsey MM, Rumbaugh KP, Whiteley M (2011) Metabolite crossfeeding enhances virulence in a model polymicrobial infection. PLoS Pathog 7:e1002012
Burmolle M, Webb JS, Rao D et al (2006) Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol 72:3916–3923
Whiteley M, Ott JR, Weaver EA et al (2001) Effects of community composition and growth rate on aquifer biofilm bacteria and their susceptibility to betadine disinfection. Environ Microbiol 3:43–52
Sutherland I (2001) Biofilm exopolysaccharides: a strong and sticky framework. Microbiology 147:3–9
Manhes P, Velicer GJ (2011) Experimental evolution of selfish policing in social bacteria. Proc Natl Acad Sci U S A 108:8357–8362
Hamilton WD (1964) The genetical evolution of social behavior. J Theor Biol 7:1–52
Strassmann JE, Gilbert OM, Queller DC (2011) Kin discrimination and cooperation in microbes. Annu Rev Microbiol 65:349–367
Julou T, Mora T, Guillon L et al (2013) Cell-cell contacts confine public goods diffusion inside Pseudomonas aeruginosa clonal microcolonies. Proc Natl Acad Sci U S A 110(31):12577–12582
Drescher K, Nadell CD, Stone HA, Wingreen NS, Bassler BL (2014) Solutions to the public goods dilemma in bacterial biofilms. Curr Biol 24:50–55
Griffin AS, West SA, Buckling A (2004) Cooperation and competition in pathogenic bacteria. Nature 430:1024–1027
West SA, Pen I, Griffin AS (2002) Conflict and cooperation: cooperation and competition between relatives. Science 296:72–75
Case TJ, Gilpin ME (1974) Interference competition and niche theory. Proc Natl Acad Sci U S A 71:3073–3077
Yamamoto K, Haruta S, Kato S et al (2010) Determinative factors of competitive advantage between aerobic bacteria for niches at the air-liquid interface. Microbes Environ 25:317–320
Bradshawa DJ, Marsha PD, Hodgson RJ et al (2002) Effects of glucose and fluoride on competition and metabolism within in vitro dental bacterial communities and biofilms. Caries Res 36:81–86
Oehmen A, Lemos PC, Carvalho G et al (2007) Advances in enhanced biological phosphorus removal: from micro to macro scale. Water Res 41:2271–2300
Weaver VB, Kolter R (2004) Burkholderiaspp. alter Pseudomonas aeruginosaphysiology through iron sequestration. J Bacteriol 186:2376–2384
Eberl HJ, Collinson S (2009) A modeling and simulation study of siderophore mediated antagonism in dual-species biofilms. Theor Biol Med Model 6:30
Graver MA, Wade JJ (2011) The role of acidification in the inhibition of Neisseria gonorrhoeaeby vaginal lactobacilli during anaerobic growth. Ann Clin Microbiol Antimicrob 10:8
Létoffé S, Audrain B, Bernier SP et al (2014) Aerial exposure to the bacterial volatile compound trimethylamine modifies antibiotic resistance of physically separated bacteria by raising culture medium pH. MBio 5:e00944
Pericone CD, Overweg K, Hermans PW et al (2000) Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniaeon other inhabitants of the upper respiratory tract. Infect Immun 68:3990–3997
Kreth J, Zhang Y, Herzberg MC (2008) Streptococcal antagonism in oral biofilms: Streptococcus sanguinisand Streptococcus gordoniiinterference with Streptococcus mutans. J Bacteriol 190:4632–4640
Gillor O, Kirkup BC, Riley MA (2004) Colicins and microcins: the next generation antimicrobials. Adv Appl Microbiol 54:129–146
Cascales E, Buchanan SK, Duche D et al (2007) Colicin biology. Microbiol Mol Biol Rev 71:158–229
Aoki SK, Pamma R, Hernday AD et al (2005) Contact-dependent inhibition of growth in Escherichia coli. Science 309:1245–1248
Kapitein N, Mogk A (2013) Deadly syringes: type VI secretion system activities in pathogenicity and interbacterial competition. Curr Opin Microbiol 16:52–58
Pukatzki S, Ma AT, Sturtevant D et al (2006) Identification of a conserved bacterial protein secretion system in VIBRIO cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A 103:1528–1533
Ho BT, Dong TG, Mekalanos JJ (2014) A view to a kill: the bacterial type VI secretion system. Cell Host Microbe 15:9–21
Schwarz S, West TE, Boyer F et al (2010) Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathog 6:e1001068
Rendueles O, Ghigo JM (2012) Multi-species biofilms: how to avoid unfriendly neighbors. FEMS Microbiol Rev 36:972–989
Banat IM, Franzetti A, Gandolfi I et al (2010) Microbial biosurfactants production, applications and future potential. Appl Microbiol Biotechnol 187:427–444
Rendueles O, Travier L, Latour-Lambert P et al (2011) Screening of Escherichia coli species biodiversity reveals new biofilm-associated antiadhesion polysaccharides. MBio 2:e00043–e00011
Kim Y, Oh S, Kim SH (2009) Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. Biochem Biophys Res Commun 379:324–329
Iwase T, Uehara Y, Shinji H et al (2010) Staphylococcus epidermidisEsp inhibits Staphylococcus aureusbiofilm formation and nasal colonization. Nature 465:346–349
Sugimoto S, Iwamoto T, Takada K et al (2013) Staphylococcus epidermidisEsp degrades specific proteins associated with Staphylococcus aureusbiofilm formation and host-pathogen interaction. J Bacteriol 195:1645–1655
Ogawa A, Furukawa S, Fujita S et al (2011) Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA. Appl Environ Microbiol 177:1572–1580
Bassler BL, Losick R (2006) Bacterially speaking. Cell 125:237–246
Fuqua C, Greenberg EP (2002) Listening in on bacteria: acylhomoserine lactone signaling. Nat Rev Mol Cell Biol 3:685–695
Augustine N, Kumar P, Thomas S (2010) Inhibition of vibrio choleraebiofilm by AiiA enzyme produced from Bacillus spp. Arch Microbiol 192:1019–1022
Chu W, Zere TR, Weber MM et al (2012) Indole production promotes Escherichia coli mixed-culture growth with Pseudomonas aeruginosaby inhibiting quorum signaling. Appl Environ Microbiol 78:411–419
Davies DG, Marques CN (2009) A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol 191:1393–1403
Boyle KE, Heilmann S, van Ditmarsch D et al (2013) Exploiting social evolution in biofilms. Curr Opin Microbiol 16:207–212
Reid G, Howard J, Gan BS (2001) Can bacterial interference prevent infection? Trends Microbiol 9:424–428
Buffie CG, Pamer EG (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13:790–801
Lloyd-Price J et al (2017) Strains, functions and dynamics in the expanded human microbiome project. Nature 550:61–66
Young VB (2017) The role of the microbiome in human health and disease: an introduction for clinicians. BMJ 356:j831
Hall-Stoodley L, Costerton JW et al (2004) Bacterial biofilms: From the natural environment to infectious diseases. Nat Rev Microbiol 2:95–108
Dang AT, Marsland BJ (2019) Microbes, metabolites, and the gut–lung axis. Mucosal Immunol 12:843–850
Tytgat HLP, Nobrega FL, Oost J et al (2019) de bowel biofilms: tipping points between a healthy and compromised gut? Trends Microbiol 27:17–25
DeVos WM (2015) Microbial biofilms and the human intestinal microbiome. NPJ Biofilms Microbiomes 1:15005
Dongari-Bagtzoglou A (2008) Mucosal biofilms: challenges and future directions. Expert Rev Anti-Infect Ther 6:141–144
Costerton JW et al (1995) Microbial biofilms. Annu Rev Microbiol 49:711–745
Jamal M et al (2018) Bacterial biofilm and associated infections. J Chin Med Assoc 81:7–11
Cho KH, Caparon MG (2005) Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol 57:1545–1556
Hall-Stoodley L, Hu FZ, Gieseke A et al (2006) Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296:202–211
Bouchet V, Hood DW, Li J et al (2003) Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc Natl Acad Sci U S A 100(15):8898–8903
Ehrlich GD, Veeh R, Wang X et al (2002) Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 287:1710–1715
Jurcisek J, Greiner L, Watanabe et al (2005) Role of sialicacid and complex carbohydrate biosynthesis in biofilm formation by nontypeableHaemophilusinfluenzae in the chinchilla middle ear. Infect Immun 73(6):3210–3218
Briles DE, Hollingshead SK, Nabors GS et al (2000) The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 19(Suppl 1):S87–S95
Holmes AR, McNab R, Millsap KW et al (2001) The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence. Mol Microbiol 41:1395–1408
Beghetto E, Gargano N, Ricci S et al (2006) Discovery of novel Streptococcus pneumonia eantigens by screening a whole-genome lambda-display library. FEMS Microbiol Lett 262(1):14–21
Byrd MS, Pang B, Hong W, Waligora et al (2011) Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model. Infect Immun 79(8):3087–3095
Roberts AL, Connolly KL, Doern CD et al (2010) Loss of the group A Streptococcus regulator Srv decreases biofilm formation in vivo in an otitis media model of infection. Infect Immun 78(11):4800–4808
Kolenbrander PE (2011) Multispecies communities: interspecies interactions influence growth on saliva as sole nutritional source. Int J Oral Sci 3(2):49–54
Groessner-Schreiber B, Hannig M, Duck A et al (2004) Do different implant surfaces exposed in the oral cavity of humans show different biofilm compositions and activities? Eur J Oral Sci 112(6):516–522
Dai T, Kharkwal GB, Tanaka M et al (2011) Animal models of external traumatic wound infections. Virulence 2:296–315
Quivey RG Jr, Kuhnert WL, Hahn K (2000) Adaptation of oral streptococci to low pH. Adv Microb Physiol 42:239–274
Fitzgerald RJ, Keyes PH (1960) Demonstration of the etiologic role of streptococci in experimental caries in the hamster. J Am Dent Assoc 61:9–19
Keyes PH (1960) The infectious and transmissible nature of experimental dental caries. Findings and implications. Arch Oral Biol 1:304–320
Tanzer JM (1979) Essential dependence of smooth surface caries on, and augmentation of fissure caries by, sucrose and Streptococcus mutans infection. Infect Immun 25(2):526–531
Bowen WH, Schilling K, Giertsen E, Pearson S et al (1991) Role of a cell surface-associated protein in adherence and dental caries. Infect Immun 59:4606–4609
Catalan MA, Scott-Anne K, Klein MI et al (2011) Elevated incidence of dental caries in a mouse model of cystic fibrosis. PLoS One 6:e16549
van Heeckeren AM, Schluchter MD, Drumm ML et al (2004) Role of Cftr genotype in the response to chronic Pseudomonas aeruginosalung infection in mice. Am J Physiol Lung Cell Mol Physiol 287(5):L944–L952
Calum H, Moser C, Jensen PO et al (2009) Thermal injury induces impaired function in polymorphonuclear neutrophil granulocytes and reduced control of burn wound infection. Clin Exp Immunol 156:102–110
Cohen TS, Prince A (2012) Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 18:509–519
Hoiby N, Bjarnsholt T, Givskov M et al (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35:322–332
Yang L, Hengzhuang W, Wu H et al (2012) Polysaccharides serve as scaffold of biofilms formed by mucoid Pseudomonas aeruginosa. FEMS Immunol Med Microbiol 65:366–376
Xiong YQ, Willard J, Yeaman MR et al (2006) Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis 194:1267–1275
James GA, Swogger E, Wolcott R et al (2008) Biofilms in chronic wounds. Wound Repair Regen 16:37–44
Thomson CH (2011) Biofilms: do they affect wound healing? Int Wound J 8:63–67
Seth AK, Geringer MR, Hong SJ et al (2012) In vivo modeling of biofilm-infected wounds: a review. J Surg Res 178:330–338
Davis SC, Ricotti C, Cazzaniga A et al (2008) Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 16:23–29
Simonetti O, Cirioni O, Ghiselli R et al (2008) RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 52(6):2205–2211
Lee FD, Kraszewski A, Gordon J et al (1971) Intestinal spirochaetosis. Gut 12:126–133
Macfarlane S, Dillon JF (2007) Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol 102:1187–1196
Palestrant D, Holzknecht ZE, Collins BH et al (2004) Microbial biofilms in the gut: visualization by electron microscopy and by acridine orange staining. Ultrastruct Pathol 28:23–27
Swidsinski A, Weber J, Loening-Baucke V et al (2005) Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43:3380–3389
Sjoerd van der Post KS, Jabbar GB et al (2019) Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis. Gut 68:2142–2151
Ellerman M, Sartor RB (2018) Intestinal bacterial biofilms modulate mucosal immune responses. J Immunol Sci 2:13–18
Monteiro C et al (2009) Characterization of cellulose production in Escherichia coli Nissle 1917 and its biological consequences. Environ Microbiol 11:1105–1116
Leatham MP, Stevenson SJ, Gauger EJ et al (2005) Mouse intestine selects no nmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and bette rutilization of carbon sources. Infect Immun 73(12):8039–8049
Leatham-Jensen MP, Frimodt-Møller J, Adediran J et al (2012) The streptomycin-treated mouse intestine selects Escherichia coli envZ missense mutants that interact with dense and diverse intestinal microbiota. Infect Immun 80(5):1716–1727
Plummer P, Sahin O, Burrough E et al (2012) Critical role of LuxS in the virulence of Campylobacter jejuni in a guinea pig model of abortion. Infect Immun 80(2):585–593
Klein RD, Hultgren SJ (2020) Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies. Nat Rev Microbiol 18(4):211–226
Foxman B (2017) Urinary tract infection syndromes: occurrence, recurrence, bacteriology, riskfactors, and diseaseburden. Infect Dis Clin N Am 28:1–13
Hannan TJ, Totsika M, Mansfield KJ et al (2012) Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 36:616–648
Ronald A (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113(Suppl 1A):14S–19S
Rosen DA, Pinkner JS, Walker JN et al (2008) Molecular variations in Klebsiellapneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract. Infect Immun 76(7):3346–3356
Blango MG, Mulvey MA (2010) Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 54:1855–1863
Hultgren SJ, Porter TN, Schaeffer AJ et al (1985) Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun 50:370–377
Langermann S, Palaszynski S, Barnhart M et al (1997) Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276(5312):607–611
Poggio TV, La Torre JL, Scodeller EA (2006) Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge. Can J Microbiol 52:1093–1102
Wullt B, Bergsten G, Connell H et al (2001) P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell Microbiol 3(4):255–264
Bergsten G, Wullt B, Svanborg C (2005) Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. Int J Med Microbiol 295(6-7):487–502
Hadjifrangiskou M, Kostakioti M, Chen SL et al (2011) A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol 80:1516–1529
Alteri CJ, Smith SN, Mobley HL (2009) Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog 5:e1000448
Reigstad CS, Hultgren SJ, Gordon JI (2007) Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem 282(29):21259–21267
Trune DR, Zheng QY (2009) Mouse models for human otitis media. Brain Res 1277:90–103
Rye MS, Wiertsema SP, Scaman ES et al (2011) FBXO11, a regulator of the TGFβ pathway, is associated with severe otitis media in Western Australian children. Genes Immun 12(5):352–359
Bhutta MF (2012) Mouse models of otitis media: strengths and limitations. Otolaryngol Head Neck Surg 147:611–614
Zhang Y, Hu Y, Yang B et al (2010) Duckweed (Lemna minor) as a model plant system for the study of human microbial pathogenesis. PLoS One 5:e13527
Lee SF, Andrian E, Rowland E, Marquez IC (2009) Immune response and alveolar bone resorption in a mouse model of Treponema denticola infection. Infect Immun 77:694–698
Bainbridge B, Verma RK, Eastman C et al (2010) Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats. Infect Immun 78:4560–4569
Feuille F, Ebersole JL, Kesavalu L et al (1996) Mixed infection with Porphyromonasgingivalis and Fusobacteriumnucleatum in a murine lesion model: potential synergistic effects on virulence. Infect Immun 64(6):2094–2100
Polak D, Wilensky A, Shapira L et al (2009) Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. J Clin Periodontol 36:406–410
Yin L, Dale BA (2007) Activation of protective responses in oral epithelial cells by Fusobacteriumnucleatum and human beta-defensin-2. J Med Microbiol 56(Pt 7):976–987
Jensen PØ, Lykkesfeldt J, Bjarnsholt T et al (2012) Poor antioxidant status exacerbates oxidative stress and inflammatory response to Pseudomonas aeruginosa lung infection in guinea pigs. Basic Clin Pharmacol Toxicol 110(4):353–358
Heeckeren A, Walenga R, Konstan MW et al (1997) Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100(11):2810–2815
Moser C et al (2017) Biofilms and host response–helpful or harmful. APMIS 125:320–338
Mauch RM et al (2017) Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis. Pathog Dis 75:10–13
González JF, Hahn MM, Gunn JS (2018) Chronic biofilm-based infections: skewing of the immune response. Pathog Dis 76:1–7
Moser C et al (2000) The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 tvpe. APMIS 108:329–335
Yonker LM, Cigana C, Hurley BP et al (2015) Host-pathogen interplay in the respiratory environment of cystic fibrosis. J Cyst Fibros 14(4):431–439
Moser C et al (2005) Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. APMIS 113:400–409
Aanaes K et al (2013) Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization. J Cyst Fibros 12:81–87
Su YC, Jalalvand F, Thegerström J, Riesbeck K (2018) The interplay between immune response and bacterial infection in COPD: focus upon non-typeable Haemophilus influenzae. Front Immunol 9:1–26
Staples KJ et al (2016) Relationships between mucosal antibodies, non-typeable Haemophilusinfluenzae (NTHi) infection and airway inflammation in COPD. PLoS ONE 11:1–17
Domingue JC, Drewes JL, Merlo CA et al (2020) Host responses to mucosal biofilms in the lung and gut. Mucosal Immunol 13(3):413–422
Abraham SN, Babu JP, Giampapa CS et al (1985) Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun 48:625–628
Wright KJ, Seed PC, Hultgren SJ (2007) Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 9:2230–2241
Fischer H, Lutay N, Ragnarsdottir B et al (2010) Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog 6:e1001109
Hannan TJ, Mysorekar IU, Hung CS et al (2010) Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 6(8):e1001042
Hagberg L, Hull R, Hull S et al (1984) Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 46(3):839–844
Svanborg C, Bergsten G, Fischer H et al (2006) Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol 9(1):33–39
Ragnarsdottir B, Jonsson K, Urbano A et al (2010) Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One 5:e10734
Sivick KE, Mobley HL (2010) Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 78:568–585
Andersen-Nissen E, Hawn TR, Smith KD et al (2007) Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol 178(8):4717–4720
Song J, Abraham SN (2008) TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol 11(1):66–73
Hansson S, Hanson E, Hjalmas K et al (1990) Follicular cystitis in girls with untreated asymptomatic or covert bacteriuria. J Urol 143:330–332
Schlager TA, LeGallo R, Innes D et al (2011) B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections. J Urol 186:2359–2364
Wang C, Mendonsa GR, Symington JW et al (2012) Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo. Proc Natl Acad Sci U S A 109:11008–11013
Darouiche RO (2004) Treatment of infections associated with surgical implants. N Engl J Med 350(14):1422–1429
Sohns JM, Bavendiek U, Ross TL et al (2017) Targeting cardiovascular implant infection: multimodality and molecular imaging. Circ Cardiovasc Imaging 10(12):e005376
Kalmeijer MD et al (2000) Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 21(5):319–323
Berbari EF, Hanssen AD, Duffy MC et al (1998) Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 27(5):1247–1254
Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271(20):1598–1601
Adair CG, Gorman SP, Feron BM et al (1999) Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 25:1072–1076
Inglis TJJ, Tit-Meng L, Mah-Lee N et al (1995) Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation. Chest 108:1049
Frank DN, Wilson SS, St Amand AL et al (2009) Culture-independent microbiological analysis of foley urinary catheter biofilms. PLoS One 4:e7811
Percival SL, Sabbuba NA, Kite P, Stickler DJ (2009) The effect of EDTA instillations on the rate of development of encrustation and biofilms in Foley catheters. Urol Res 37(4):205–209
Macleod SM, Stickler DJ (2007) Species interactions in mixed-community crystalline biofilms on urinary catheters. J Med Microbiol 56:1549–1557
Richards MJ, Edwards JR, Culver DH (1999) Gaynes RP Nosocomial infections in medical intensive care units in the United States. National nosocomial infections surveillance system. Crit Care Med 27:887–892
Rello J, Ochagavia A, Sabanes E et al (2000) Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162:1027–1030
Raad II (1994) The pathogenesis and prevention of central venous catheter-related infections. Middle East J Anaesthesiol 12(4):381–403
Arciola CR, An YH, Campoccia D et al (2005) Etiology of implant orthopedic infections: a survey on 1027 clinical isolates. Int J Artif Organs 28:1091–1100
Vongpatanasin W, Hillis LD, Lange RA (1996) Prosthetic heart valves. N Engl J Med 335:407–416
Renvert S, Lindahl C, Renvert H et al (2008) Clinical and microbiological analysis of subjects treated with Branemark or AstraTech implants: a 7-year follow-up study. Clin Oral Implants Res 19(4):342–347
Jacombs A, Tahir S, Hu H et al (2014) In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg 133(4):471e–480e
Teughels W, Van Assche N, Sliepen I et al (2006) Effect of material characteristics and/or surface topography on biofilm development. Clin Oral Implants Res 17(Suppl 2):68–81
Charalampakis G, Ramberg P, Dahlen G et al (2014) Effect of cleansing of biofilm formed on titanium discs. Clin Oral Implants Res 26:12397
Astrand P, Engquist B, Dahlgren S et al (2004) Astra Tech and Branemark system implants: a 5-year prospective study of marginal bonereactions. Clin Oral Implants Res 15(4):413–420
Esposito M, Murray-Curtis L, Grusovin MG et al (2007) Interventions for replacing missing teeth: different types of dental implants. Cochrane Database Syst Rev 4:CD003815
Gotfredsen K, Karlsson U (2001) A prospective 5-year study of fixed partial prostheses supported by implants with machined and TiO2-blasted surface. J Prosthodont 10(1):2–7
Wennstrom JL, Ekestubbe A, Grondahl K et al (2004) Oral rehabilitation with implant-supported fixed partial dentures in periodontitis-susceptible subjects. A 5-year prospective study. J Clin Periodontol 31(9):713–724
Darouiche RO (2001) Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 33:1567–1572
Kolenbrander PE, Palmer RJ Jr, Periasamy S et al (2010) Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8(7):471–480
Busscher HJ, Rinastiti M, Siswomihardjo W et al (2010) Biofilm formation on dental restorative and implant materials. J Dent Res 89(7):657–665
Foster SJ (1995) Molecular characterization and functional analysis of the major autolysin of Staphylococcus aureus 8325/4. J Bacteriol 177:5723–5725
Costerton JW (1995) Overview of microbial biofilms. J Ind Microbiol 15:137–140
Klausen M, Heydorn A, Ragas P et al (2003) Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48:1511–1524
Beloin C, Roux A, Ghigo JM (2008) Escherichia coli biofilms. Curr Top Microbiol Immunol 322:249–289
Cookson AL, Cooley WA, Woodward MJ (2002) The role of type 1 and curli fimbriae of Shiga toxin-producing Escherichia coli in adherence to abiotic surfaces. Int J Med Microbiol 292:195–205
Mohamed JA, Huang W, Nallapareddy SR et al (2004) Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect Immun 72:3658–3663
Kemp KD, Singh KV, Nallapareddy SR et al (2007) Relative contributions of Enterococcusfaecalis OG1RF sortase-encodinggenes, srtA and bps (srtC), to biofilm formation and a murine model of urinary tract infection. Infect Immun 75:5399–5404
Rohde H, Burandt EC, Siemssen N et al (2007) Polysaccharide intercellularadhesin or proteinfactors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 28:1711–1720
Mehall JR, Saltzman DA, Jackson RJ et al (2002) Fibrin sheath enhances central venous catheter infection. Crit Care Med 30:908–912
Vroman L, Adams AL, Fischer GC et al (1980) Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55:156–159
Franz S, Rammelt S, Scharnweber D et al (2011) Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32:6692–6709
Selders GS et al (2017) An overview of the role of neutrophils in innate immunity, inflammation and host- biomaterial integration. Regen Biomater 4:55–68
Brinkmann V et al (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535
Patel JD, Krupka T, Anderson JM (2007) iNOS-mediated generation of reactive oxygen and nitrogen species by biomaterial-adherent neutrophils. J Biomed Mater Res A 80:381–390
Zimmerli W, Waldvogel FA, Vaudaux P et al (1982) Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 146(4):487–497
Crémet L et al (2016) Innate immune evasion of Escherichia coli clinical strains from orthopedic implant infections. Eur J Clin Microbiol Infect Dis 35:993–999
Scherr TD et al (2015) Staphylococcus aureus biofilms induce macrophage dysfunction through leukocidin AB and alpha- toxin. MBio 6:e01021–e01015
Peschel A, Otto M (2013) Phenol- soluble modulins and staphylococcal infection. Nat Rev Microbiol 11:667–673
Alexander EH et al (2003) Staphylococcus aureus-induced tumor necrosis factor – related apoptosis–inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts. BMC Microbiol 3:5–16
Bui LM, Conlon BP, Kidd SP (2017) Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus. Essays Biochem 61:71–79
Proctor RA et al (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4:295–305
Sendi P et al (2006) Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 43:961–967
deMesy Bentley KL et al (2017) Evidence of Staphylococcus aureus deformation, proliferation, and migration in canaliculi of live cortical bone in murine models of osteomyelitis. J Bone Miner Res 32:985–990
Hamza T et al (2013) Intra-cellular Staphylococcus aureus alone causes infection in vivo. Eur Cell Mater 25:341–350
Gristina AG, Costerton JW (1984) Bacterial adherence and the glycocalyx and their role in musculoskeletal infection. Orthop Clin North Am 15:517–535
Prabhakara R, Harro JM, Leid JG et al (2011) Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureus. Infect Immun 79:5010–5018
Lucke M, Schmidmaier G, Sadoni S et al (2003) Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32:521–531
Lucke M, Wildemann B, Sadoni S et al (2005) Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone 36:770–778
Berra L, De Marchi L, Yu ZX et al (2004) Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube. Anesthesiology 100:1446–1456
Kollef MH, Afessa B, Anzueto A et al (2008) Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 300:805–813
Tollefson DF, Bandyk DF, Kaebnick HW et al (1987) Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses. Arch Surg 122:38–43
Gahtan V, Esses GE, Bandyk DF et al (1995) Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts. J Surg Res 58:105–110
Aboshady I, Raad I, Shah AS et al (2012) A pilot study of a triple antimicrobial-bonded Dacron graft for the prevention of aortic graft infection. J Vasc Surg 56:794–801
Haraoka M, Matsumoto T, Takahashi K et al (1995) Effect of prednisolone on ascending renal infection due to biofilm disease and lower urinary tract obstruction in rats. Urol Res 22:383–387
Allison KR, Brynildsen MP, Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473:216–220
Fung LC, Mittelman MW, Thorner PS et al (2003) A novel rabbit model for the evaluation of biomaterial associated urinary tract infection. Can J Urol 10:2007–2012
Rupp ME, Ulphani JS, Fey PD, Mack D (1999) Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect Immun 67:2656–2659
Rupp ME, Fey PD, Heilmann C, Gotz F (2001) Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis 183:1038–1042
Chauhan A, Lebeaux D, Decante B, Kriegel I, Escande MC, Ghigo JM, Beloin C (2012) A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One 7:e37281
Chauhan A, Ghigo JM, Beloin C (2016) Study of in vivo catheter biofilm infections using pediatric central venous catheter implanted in rat. Nat Protoc 11(3):525–541
Chauhan A, Lebeaux D, Ghigo JM, Beloin C (2012) Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother 56:6310–6318
Chauhan A, Bernardin A, Mussard W et al (2014) Preventing biofilm formation and associated occlusion by biomimetic glycocalyxlike polymer in central venous catheters. J Infect Dis 210(9):1347–1356
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Bhowmik, A., Malhotra, A., Jana, S., Chauhan, A. (2021). Biofilm Formation and Pathogenesis. In: Nag, M., Lahiri, D. (eds) Analytical Methodologies for Biofilm Research. Springer Protocols Handbooks. Springer, New York, NY. https://doi.org/10.1007/978-1-0716-1378-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1378-8_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-0716-1377-1
Online ISBN: 978-1-0716-1378-8
eBook Packages: Springer Protocols